Working to facilitate rapid translation of scientific discoveries into therapeutics

Thomas Stoehr


Thomas Stoehr, PhD

Thomas received a PhD in Pharmacology from the Max Planck Institute of Psychiatry in Munich and subsequently worked as a lecturer and researcher in Behavioural Pharmacology at the Swiss Federal Institute of Technology. After several years in academia he decided to join the pharmaceutical industry (Roche, Janssen, Schwarz, UCB) and contributed to the development and market authorization of several drugs. More recently, Thomas pursued his career in biotech companies: After several years as head of development at bitop he founded A2M Pharma GmbH and acts as its managing director. Since 2011 he is head of translational medicine at Ablynx.

2013-2021©European Society for Translational Medicine (EUSTM)